Esperion Therapeutics Eulerpool News

Esperion Therapeutics Eulerpool News

Esperion Therapeutics Stock News

Esperion Therapeutics is being monitored by journalists and investors worldwide. We gather the latest Esperion Therapeutics news here.

• September 11 ·

  Yahoo
  Why Is Esperion Therapeutics (ESPR) Down 3.9% Since Last Earnings Report?
• September 5 ·

  Yahoo
  Esperion to Participate in Upcoming 2024 Cantor Global Healthcare Conference
• September 4 ·

  Stock Options Channel
  Commit To Purchase Esperion Therapeutics At $1.50, Earn 36% Annualized Using Options
• September 3 ·

  Yahoo
  Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe)
• September 3 ·

  TipRanks
  Market Outperform: Enhanced Insurance Coverage and FDA Approvals Propel Esperion’s Growth Potential
• September 3 ·

  GlobeNewswire
  Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL? (bempedoic acid) and NEXLIZET? (bempedoic acid and ezetimibe)
• September 3 ·

  Thefly.com
  Esperion secures additional commercial, Medicare formulary coverage for NEXLETOL
• August 26 ·

  Yahoo
  Esperion to Participate in Upcoming H.C. Wainwright 26th Annual Global Investment Conference
• August 19 ·

  SeekingAlpha
  Esperion Therapeutics: Delivering On Expectations While Navigating Overhangs
• August 16 ·

  SeekingAlpha
  Esperion Therapeutics: Strategically Positioned To Grow